Immunoengineered adjuvants for universal vaccines against respiratory viruses.
作者信息
Wang Ji, Xie Xi, Jiang Shibo, Lu Lu
机构信息
Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
State Key Laboratory of Optoelectronic Materials and Technologies, School of Electronics and Information Technology, Sun Yat-sen University, Guangzhou 510006, China.
出版信息
Fundam Res. 2021 Mar;1(2):189-192. doi: 10.1016/j.fmre.2021.01.010. Epub 2021 Jan 22.
Abstract
摘要
相似文献
1
Immunoengineered adjuvants for universal vaccines against respiratory viruses.用于抗呼吸道病毒通用疫苗的免疫工程佐剂。
Fundam Res. 2021 Mar;1(2):189-192. doi: 10.1016/j.fmre.2021.01.010. Epub 2021 Jan 22.
2
Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses.多聚 COBRA 血凝素与 cGAMP 微粒制剂诱导针对流感病毒的保护性免疫应答。
mSphere. 2024 Jul 30;9(7):e0016024. doi: 10.1128/msphere.00160-24. Epub 2024 Jun 26.
3
Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses.由保守的流感蛋白和 GPI 锚定的 CCL28/GM-CSF 融合蛋白组成的流感病毒样颗粒增强了针对同源和异源病毒的保护性免疫。
Int Immunopharmacol. 2018 Oct;63:119-128. doi: 10.1016/j.intimp.2018.07.011. Epub 2018 Aug 3.
4
Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.用δ-菊粉佐剂配制的严重急性呼吸综合征相关冠状病毒疫苗在改善肺部嗜酸性粒细胞免疫病理学的同时提供了增强的保护作用。
J Virol. 2015 Mar;89(6):2995-3007. doi: 10.1128/JVI.02980-14. Epub 2014 Dec 17.
5
Universal influenza vaccines: Shifting to better vaccines.通用流感疫苗：转向更好的疫苗。
Vaccine. 2016 Jun 3;34(26):2926-2933. doi: 10.1016/j.vaccine.2016.03.085. Epub 2016 Mar 31.
6
Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery.评估双病原体识别受体激动剂作为呼吸道合胞病毒-病毒样颗粒肺部给药佐剂的效果。
Front Immunol. 2025 Mar 17;16:1561297. doi: 10.3389/fimmu.2025.1561297. eCollection 2025.
7
Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.用于鸡用高致病性禽流感病毒疫苗的10种不同佐剂的免疫学评估。
Vaccine. 2017 Jun 8;35(26):3401-3408. doi: 10.1016/j.vaccine.2017.05.010. Epub 2017 May 13.
8
Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants.表观遗传佐剂：用佐剂对固有免疫系统进行持久重编程。
Curr Opin Immunol. 2022 Aug;77:102189. doi: 10.1016/j.coi.2022.102189. Epub 2022 May 16.
9
Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.用于新生儿的呼吸道病毒病原体疫苗：机遇与挑战
J Immunol. 2014 Dec 1;193(11):5363-9. doi: 10.4049/jimmunol.1401410.
10
Establishment of a novel adjuvant screening system for the development of intranasal vaccine adjuvants.建立用于鼻内疫苗佐剂开发的新型佐剂筛选系统。
Vaccine. 2025 Jun 11;58:127267. doi: 10.1016/j.vaccine.2025.127267. Epub 2025 May 17.
引用本文的文献
1
Multilayered precision regulation to induce robust CD8 T-cell immune responses.多层精确调控以诱导强大的CD8 T细胞免疫反应。
Clin Transl Med. 2025 Jun;15(6):e70375. doi: 10.1002/ctm2.70375.
本文引用的文献
1
Proton-driven transformable nanovaccine for cancer immunotherapy.质子驱动可变形纳米疫苗用于癌症免疫治疗。
Nat Nanotechnol. 2020 Dec;15(12):1053-1064. doi: 10.1038/s41565-020-00782-3. Epub 2020 Oct 26.
2
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染：一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
3
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.SARS-CoV-2 重组刺突蛋白纳米颗粒疫苗的 1/2 期临床试验。
N Engl J Med. 2020 Dec 10;383(24):2320-2332. doi: 10.1056/NEJMoa2026920. Epub 2020 Sep 2.
4
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.新型冠状病毒灭活疫苗在安全性和免疫原性方面的效果：两项随机临床试验的中期分析。
JAMA. 2020 Sep 8;324(10):951-960. doi: 10.1001/jama.2020.15543.
5
Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model.先前存在的对流感病毒血凝素茎的免疫可能会在人体挑战模型中推动对抗体逃逸突变病毒的选择。
Nat Med. 2020 Aug;26(8):1240-1246. doi: 10.1038/s41591-020-0937-x. Epub 2020 Jun 29.
6
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity.肺表面活性剂仿生纳米颗粒增强了异源流感免疫。
Science. 2020 Feb 21;367(6480). doi: 10.1126/science.aau0810.
7
Human CD8 T cell cross-reactivity across influenza A, B and C viruses.人类 CD8 T 细胞对甲型、乙型和丙型流感病毒的交叉反应性。
Nat Immunol. 2019 May;20(5):613-625. doi: 10.1038/s41590-019-0320-6. Epub 2019 Feb 18.
8
Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic.研发通用流感疫苗：从 1918 年大流感中汲取的教训。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S5-S13. doi: 10.1093/infdis/jiy728.
9
Physical activation of innate immunity by spiky particles.刺突颗粒对固有免疫的物理激活。
Nat Nanotechnol. 2018 Nov;13(11):1078-1086. doi: 10.1038/s41565-018-0274-0. Epub 2018 Oct 29.
10
Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine.追踪季节性流感——通用流感疫苗的必要性
N Engl J Med. 2018 Jan 4;378(1):7-9. doi: 10.1056/NEJMp1714916. Epub 2017 Nov 29.
Zotero 插件